JP2018518163A5 - - Google Patents

Download PDF

Info

Publication number
JP2018518163A5
JP2018518163A5 JP2017559861A JP2017559861A JP2018518163A5 JP 2018518163 A5 JP2018518163 A5 JP 2018518163A5 JP 2017559861 A JP2017559861 A JP 2017559861A JP 2017559861 A JP2017559861 A JP 2017559861A JP 2018518163 A5 JP2018518163 A5 JP 2018518163A5
Authority
JP
Japan
Prior art keywords
lytic bacteriophage
repeat
spacer
lytic
type
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2017559861A
Other languages
English (en)
Japanese (ja)
Other versions
JP7051438B2 (ja
JP2018518163A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/037493 external-priority patent/WO2016205276A1/en
Publication of JP2018518163A publication Critical patent/JP2018518163A/ja
Publication of JP2018518163A5 publication Critical patent/JP2018518163A5/ja
Priority to JP2022054902A priority Critical patent/JP7290368B2/ja
Application granted granted Critical
Publication of JP7051438B2 publication Critical patent/JP7051438B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2017559861A 2015-06-15 2016-06-15 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物 Active JP7051438B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022054902A JP7290368B2 (ja) 2015-06-15 2022-03-30 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562175749P 2015-06-15 2015-06-15
US62/175,749 2015-06-15
PCT/US2016/037493 WO2016205276A1 (en) 2015-06-15 2016-06-15 Methods and compositions for efficient delivery of nucleic acids and rna-based antimicrobials

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022054902A Division JP7290368B2 (ja) 2015-06-15 2022-03-30 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物

Publications (3)

Publication Number Publication Date
JP2018518163A JP2018518163A (ja) 2018-07-12
JP2018518163A5 true JP2018518163A5 (enExample) 2019-07-18
JP7051438B2 JP7051438B2 (ja) 2022-04-11

Family

ID=57546192

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2017559861A Active JP7051438B2 (ja) 2015-06-15 2016-06-15 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物
JP2022054902A Active JP7290368B2 (ja) 2015-06-15 2022-03-30 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物
JP2023084331A Pending JP2023109907A (ja) 2015-06-15 2023-05-23 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2022054902A Active JP7290368B2 (ja) 2015-06-15 2022-03-30 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物
JP2023084331A Pending JP2023109907A (ja) 2015-06-15 2023-05-23 核酸およびrnaに基づく抗菌剤の効率的な送達のための方法および組成物

Country Status (11)

Country Link
US (2) US11155823B2 (enExample)
EP (2) EP3307872B1 (enExample)
JP (3) JP7051438B2 (enExample)
KR (1) KR102468240B1 (enExample)
CN (2) CN107922918B (enExample)
AU (2) AU2016280002B2 (enExample)
CA (1) CA2983874C (enExample)
DK (1) DK3307872T3 (enExample)
ES (1) ES2960226T3 (enExample)
FI (1) FI3307872T3 (enExample)
WO (1) WO2016205276A1 (enExample)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013066438A2 (en) 2011-07-22 2013-05-10 President And Fellows Of Harvard College Evaluation and improvement of nuclease cleavage specificity
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
US9359599B2 (en) 2013-08-22 2016-06-07 President And Fellows Of Harvard College Engineered transcription activator-like effector (TALE) domains and uses thereof
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
US9388430B2 (en) 2013-09-06 2016-07-12 President And Fellows Of Harvard College Cas9-recombinase fusion proteins and uses thereof
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
WO2015066119A1 (en) 2013-10-30 2015-05-07 North Carolina State University Compositions and methods related to a type-ii crispr-cas system in lactobacillus buchneri
US11053481B2 (en) 2013-12-12 2021-07-06 President And Fellows Of Harvard College Fusions of Cas9 domains and nucleic acid-editing domains
CN106460003A (zh) 2014-04-08 2017-02-22 北卡罗来纳州立大学 用于使用crispr相关基因rna引导阻遏转录的方法和组合物
AU2015298571B2 (en) 2014-07-30 2020-09-03 President And Fellows Of Harvard College Cas9 proteins including ligand-dependent inteins
WO2016033298A1 (en) 2014-08-28 2016-03-03 North Carolina State University Novel cas9 proteins and guiding features for dna targeting and genome editing
DE112016002056T5 (de) 2015-05-06 2018-02-08 Snipr Technologies Limited Verändern mikrobieller Populationen und Modifizieren von Mikrobiomen
EP3303607A4 (en) 2015-05-29 2018-10-10 North Carolina State University Methods for screening bacteria, archaea, algae, and yeast using crispr nucleic acids
WO2017058751A1 (en) 2015-09-28 2017-04-06 North Carolina State University Methods and compositions for sequence specific antimicrobials
US12043852B2 (en) 2015-10-23 2024-07-23 President And Fellows Of Harvard College Evolved Cas9 proteins for gene editing
EP3368687B1 (en) * 2015-10-27 2021-09-29 The Broad Institute, Inc. Compositions and methods for targeting cancer-specific sequence variations
WO2017087909A1 (en) 2015-11-19 2017-05-26 Epibiome, Inc. Bacteriophage compositions and methods of use thereof
WO2017112620A1 (en) 2015-12-22 2017-06-29 North Carolina State University Methods and compositions for delivery of crispr based antimicrobials
GB201609811D0 (en) 2016-06-05 2016-07-20 Snipr Technologies Ltd Methods, cells, systems, arrays, RNA and kits
KR20250103795A (ko) 2016-08-03 2025-07-07 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 아데노신 핵염기 편집제 및 그의 용도
CN109804066A (zh) 2016-08-09 2019-05-24 哈佛大学的校长及成员们 可编程cas9-重组酶融合蛋白及其用途
US11542509B2 (en) 2016-08-24 2023-01-03 President And Fellows Of Harvard College Incorporation of unnatural amino acids into proteins using base editing
AU2017342543B2 (en) 2016-10-14 2024-06-27 President And Fellows Of Harvard College AAV delivery of nucleobase editors
WO2018119359A1 (en) 2016-12-23 2018-06-28 President And Fellows Of Harvard College Editing of ccr5 receptor gene to protect against hiv infection
AU2018217936A1 (en) * 2017-02-10 2019-08-29 Eth Zurich Rebooting of synthetic bacteriophage genome in L-form bacteria
EP3592853A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Suppression of pain by gene editing
EP3592381A1 (en) 2017-03-09 2020-01-15 President and Fellows of Harvard College Cancer vaccine
KR20190127797A (ko) 2017-03-10 2019-11-13 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 시토신에서 구아닌으로의 염기 편집제
CA3057192A1 (en) 2017-03-23 2018-09-27 President And Fellows Of Harvard College Nucleobase editors comprising nucleic acid programmable dna binding proteins
WO2018209320A1 (en) 2017-05-12 2018-11-15 President And Fellows Of Harvard College Aptazyme-embedded guide rnas for use with crispr-cas9 in genome editing and transcriptional activation
JP2020525049A (ja) * 2017-06-25 2020-08-27 エスエヌアイピーアール・テクノロジーズ・リミテッドSnipr Technologies Limited 微生物集団の変更及び細菌叢の改変
CN111801345A (zh) 2017-07-28 2020-10-20 哈佛大学的校长及成员们 使用噬菌体辅助连续进化(pace)的进化碱基编辑器的方法和组合物
GB201712733D0 (en) * 2017-08-08 2017-09-20 Snipr Tech Ltd Methods & cells
CN107447044A (zh) * 2017-08-09 2017-12-08 华子昂 一种检测大肠杆菌λ噬菌体全基因组碱基修饰单倍型的方法
CN107365804B (zh) * 2017-08-13 2019-12-20 中国人民解放军疾病预防控制所 一种使用温和噬菌体载体包装CRISPR-Cas9系统的方法
WO2019139645A2 (en) 2017-08-30 2019-07-18 President And Fellows Of Harvard College High efficiency base editors comprising gam
CA3082251A1 (en) 2017-10-16 2019-04-25 The Broad Institute, Inc. Uses of adenosine base editors
EP3724214A4 (en) 2017-12-15 2021-09-01 The Broad Institute Inc. SYSTEMS AND METHODS FOR PREDICTING REPAIR RESULTS IN GENETIC ENGINEERING
CN108300732A (zh) * 2018-02-23 2018-07-20 上海交通大学 一种高转化率运动发酵单胞菌及其构建方法和应用
US10760075B2 (en) 2018-04-30 2020-09-01 Snipr Biome Aps Treating and preventing microbial infections
EP4066851A1 (en) * 2018-03-25 2022-10-05 SNIPR Biome ApS. Treating & preventing microbial infections
KR20210018273A (ko) * 2018-05-04 2021-02-17 로커스 바이오사이언스, 인크. 표적 박테리아를 사멸시키기 위한 방법 및 조성물
CN112236517A (zh) * 2018-05-22 2021-01-15 学校法人自治医科大学 抗菌噬菌体、治疗用组合物、杀菌剂、食品、细菌鉴别试剂盒、治疗用组合物制造方法、细菌去除方法、细菌鉴别方法及动物治疗方法
WO2019226953A1 (en) 2018-05-23 2019-11-28 The Broad Institute, Inc. Base editors and uses thereof
US12227776B2 (en) 2018-06-13 2025-02-18 Caribou Biosciences, Inc. Engineered cascade components and cascade complexes
US10227576B1 (en) 2018-06-13 2019-03-12 Caribou Biosciences, Inc. Engineered cascade components and cascade complexes
US12264313B2 (en) 2018-10-01 2025-04-01 North Carolina State University Recombinant type I CRISPR-Cas system and uses thereof for genome modification and alteration of expression
EP3861120A4 (en) * 2018-10-01 2023-08-16 North Carolina State University Recombinant type i crispr-cas system
US12203123B2 (en) 2018-10-01 2025-01-21 North Carolina State University Recombinant type I CRISPR-Cas system and uses thereof for screening for variant cells
US12264330B2 (en) 2018-10-01 2025-04-01 North Carolina State University Recombinant type I CRISPR-Cas system and uses thereof for killing target cells
US11851663B2 (en) * 2018-10-14 2023-12-26 Snipr Biome Aps Single-vector type I vectors
US12281338B2 (en) 2018-10-29 2025-04-22 The Broad Institute, Inc. Nucleobase editors comprising GeoCas9 and uses thereof
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
US12180487B2 (en) * 2019-02-06 2024-12-31 Fred Hutchinson Cancer Center Minicircle producing bacteria engineered to differentially methylate nucleic acid molecules therein
DE112020001306T5 (de) 2019-03-19 2022-01-27 Massachusetts Institute Of Technology Verfahren und zusammensetzungen zur editierung von nukleotidsequenzen
US12473543B2 (en) 2019-04-17 2025-11-18 The Broad Institute, Inc. Adenine base editors with reduced off-target effects
US12435330B2 (en) 2019-10-10 2025-10-07 The Broad Institute, Inc. Methods and compositions for prime editing RNA
WO2021092249A1 (en) * 2019-11-06 2021-05-14 Locus Biosciences, Inc. Crispr cas systems and lysogeny modules
JP2023500336A (ja) * 2019-11-06 2023-01-05 ローカス バイオサイエンシーズ,インク. Crispr-casシステムを含むファージ組成物およびその使用方法
US12098372B2 (en) 2019-12-30 2024-09-24 Eligo Bioscience Microbiome modulation of a host by delivery of DNA payloads with minimized spread
US11584781B2 (en) 2019-12-30 2023-02-21 Eligo Bioscience Chimeric receptor binding proteins resistant to proteolytic degradation
US11746352B2 (en) * 2019-12-30 2023-09-05 Eligo Bioscience Microbiome modulation of a host by delivery of DNA payloads with minimized spread
JP2023525304A (ja) 2020-05-08 2023-06-15 ザ ブロード インスティテュート,インコーポレーテッド 標的二本鎖ヌクレオチド配列の両鎖同時編集のための方法および組成物
GB202007943D0 (en) 2020-05-27 2020-07-08 Snipr Biome Aps Products & methods
CA3197191A1 (en) * 2020-11-05 2022-05-12 Paul GAROFOLO Phage compositions for pseudomonas comprising crispr-cas systems and methods of use thereof
JP2023548580A (ja) * 2020-11-05 2023-11-17 ローカス バイオサイエンシーズ,インク. Crispr-cas系を含むエシェリキア属に対するファージ組成物およびその使用方法
WO2023288250A1 (en) * 2021-07-15 2023-01-19 North Carolina State University Compositions, methods, and systems for enhanced dna transformation in bacteria
WO2023111286A1 (en) 2021-12-17 2023-06-22 Snipr Biome Aps Nucleic acid delivery methods and compositions
GB202209518D0 (en) 2022-06-29 2022-08-10 Snipr Biome Aps Treating & preventing E coli infections
KR20250060133A (ko) 2023-10-24 2025-05-07 중앙대학교 산학협력단 CRISPR-Cas 탑재 박테리오파지 및 이의 용도

Family Cites Families (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4723202A (en) 1987-04-02 1988-02-02 The Garrett Corporation Converter-fed AC machine without damper winding
US20050118719A1 (en) * 2001-11-07 2005-06-02 Schmidt Michael G. Nucleic acid delivery and expression
US7919277B2 (en) 2004-04-28 2011-04-05 Danisco A/S Detection and typing of bacterial strains
EP1874110A4 (en) 2005-04-15 2009-06-10 Del Monte Fresh Produce Compan VEGETABLE PROMOTERS, TERMINATORS, GENES, VECTORS AND RELATED TRANSFORMED PLANTS
US9816140B2 (en) * 2006-05-19 2017-11-14 Dupont Nutrition Biosciences Aps Tagged microorganisms and methods of tagging
NZ579002A (en) 2007-03-02 2012-03-30 Danisco Cultures with improved phage resistance
MX337838B (es) 2008-11-07 2016-03-22 Dupont Nutrition Biosci Aps Secuencias de repetidos palindromicos cortos regularmente intercalados agrupados de bifidobacterias.
WO2010075424A2 (en) 2008-12-22 2010-07-01 The Regents Of University Of California Compositions and methods for downregulating prokaryotic genes
EP2630156B1 (en) 2010-10-20 2018-08-22 DuPont Nutrition Biosciences ApS Lactococcus crispr-cas sequences
WO2012164565A1 (en) 2011-06-01 2012-12-06 Yeda Research And Development Co. Ltd. Compositions and methods for downregulating prokaryotic genes
ES2609313T3 (es) * 2011-06-29 2017-04-19 Affinity Biosciences Pty Ltd Método de expresión de proteínas
GB201122458D0 (en) * 2011-12-30 2012-02-08 Univ Wageningen Modified cascade ribonucleoproteins and uses thereof
US9637739B2 (en) 2012-03-20 2017-05-02 Vilnius University RNA-directed DNA cleavage by the Cas9-crRNA complex
WO2013141680A1 (en) 2012-03-20 2013-09-26 Vilnius University RNA-DIRECTED DNA CLEAVAGE BY THE Cas9-crRNA COMPLEX
FI3597749T3 (fi) 2012-05-25 2023-10-09 Univ California Menetelmiä ja koostumuksia rna-ohjattua kohde-dna-modifikaatiota varten ja rna-ohjattua transkription modulaatiota varten
CN104540382A (zh) 2012-06-12 2015-04-22 弗·哈夫曼-拉罗切有限公司 用于产生条件性敲除等位基因的方法和组合物
WO2013188638A2 (en) 2012-06-15 2013-12-19 The Regents Of The University Of California Endoribonucleases and methods of use thereof
EP2880171B1 (en) 2012-08-03 2018-10-03 The Regents of The University of California Methods and compositions for controlling gene expression by rna processing
KR101656236B1 (ko) 2012-10-23 2016-09-12 주식회사 툴젠 표적 DNA에 특이적인 가이드 RNA 및 Cas 단백질을 암호화하는 핵산 또는 Cas 단백질을 포함하는, 표적 DNA를 절단하기 위한 조성물 및 이의 용도
WO2014071235A1 (en) 2012-11-01 2014-05-08 Massachusetts Institute Of Technology Genetic device for the controlled destruction of dna
PT3363902T (pt) 2012-12-06 2019-12-19 Sigma Aldrich Co Llc Modificação e regulação de genoma baseadas em crispr
WO2014093479A1 (en) 2012-12-11 2014-06-19 Montana State University Crispr (clustered regularly interspaced short palindromic repeats) rna-guided control of gene regulation
EP2931898B1 (en) 2012-12-12 2016-03-09 The Broad Institute, Inc. Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains
EP4282970A3 (en) 2012-12-17 2024-01-17 President and Fellows of Harvard College Rna-guided human genome engineering
US9988625B2 (en) 2013-01-10 2018-06-05 Dharmacon, Inc. Templates, libraries, kits and methods for generating molecules
EP3919505B1 (en) 2013-01-16 2023-08-30 Emory University Uses of cas9-nucleic acid complexes
WO2014124226A1 (en) 2013-02-07 2014-08-14 The Rockefeller University Sequence specific antimicrobials
AU2014235794A1 (en) 2013-03-14 2015-10-22 Caribou Biosciences, Inc. Compositions and methods of nucleic acid-targeting nucleic acids
US20140273235A1 (en) 2013-03-15 2014-09-18 Regents Of The University Of Minnesota ENGINEERING PLANT GENOMES USING CRISPR/Cas SYSTEMS
KR102874079B1 (ko) 2013-03-15 2025-10-22 더 제너럴 하스피탈 코포레이션 Rna-안내 게놈 편집을 위해 특이성을 증가시키기 위한 절단된 안내 rna(tru-grnas)의 이용
US20140273230A1 (en) 2013-03-15 2014-09-18 Sigma-Aldrich Co., Llc Crispr-based genome modification and regulation
WO2014186686A2 (en) 2013-05-17 2014-11-20 Two Blades Foundation Targeted mutagenesis and genome engineering in plants using rna-guided cas nucleases
US9873907B2 (en) 2013-05-29 2018-01-23 Agilent Technologies, Inc. Method for fragmenting genomic DNA using CAS9
DK3004337T3 (da) 2013-05-29 2017-11-13 Cellectis Fremgangsmåde til konstruktion af T-celler til immunoterapi ved brug af RNA-guidet Cas nuklease-system
EP3004349B1 (en) 2013-05-29 2018-03-28 Cellectis S.A. A method for producing precise dna cleavage using cas9 nickase activity
US20140356956A1 (en) 2013-06-04 2014-12-04 President And Fellows Of Harvard College RNA-Guided Transcriptional Regulation
US9982277B2 (en) 2013-06-11 2018-05-29 The Regents Of The University Of California Methods and compositions for target DNA modification
EP3674411A1 (en) 2013-06-17 2020-07-01 The Broad Institute, Inc. Delivery, engineering and optimization of tandem guide systems, methods and compositions for sequence manipulation
EP3725885A1 (en) 2013-06-17 2020-10-21 The Broad Institute, Inc. Functional genomics using crispr-cas systems, compositions methods, screens and applications thereof
US20150044192A1 (en) 2013-08-09 2015-02-12 President And Fellows Of Harvard College Methods for identifying a target site of a cas9 nuclease
EP3611268A1 (en) 2013-08-22 2020-02-19 E. I. du Pont de Nemours and Company Plant genome modification using guide rna/cas endonuclease systems and methods of use
WO2015034872A2 (en) * 2013-09-05 2015-03-12 Massachusetts Institute Of Technology Tuning microbial populations with programmable nucleases
US9340799B2 (en) 2013-09-06 2016-05-17 President And Fellows Of Harvard College MRNA-sensing switchable gRNAs
EP3988649B1 (en) 2013-09-18 2024-11-27 Kymab Limited Methods, cells and organisms
US20150098954A1 (en) 2013-10-08 2015-04-09 Elwha Llc Compositions and Methods Related to CRISPR Targeting
WO2015066119A1 (en) 2013-10-30 2015-05-07 North Carolina State University Compositions and methods related to a type-ii crispr-cas system in lactobacillus buchneri
WO2015070193A1 (en) 2013-11-11 2015-05-14 Liu Oliver Compositions and methods for targeted gene disruption in prokaryotes
US20160298096A1 (en) 2013-11-18 2016-10-13 Crispr Therapeutics Ag Crispr-cas system materials and methods
US10787684B2 (en) 2013-11-19 2020-09-29 President And Fellows Of Harvard College Large gene excision and insertion
US11053481B2 (en) 2013-12-12 2021-07-06 President And Fellows Of Harvard College Fusions of Cas9 domains and nucleic acid-editing domains
EP3080266B1 (en) 2013-12-12 2021-02-03 The Regents of The University of California Methods and compositions for modifying a single stranded target nucleic acid
EP3080271B1 (en) 2013-12-12 2020-02-12 The Broad Institute, Inc. Systems, methods and compositions for sequence manipulation with optimized functional crispr-cas systems
EP3097212A4 (en) 2014-01-24 2017-10-04 North Carolina State University Methods and compositions for sequences guiding cas9 targeting
US10787654B2 (en) 2014-01-24 2020-09-29 North Carolina State University Methods and compositions for sequence guiding Cas9 targeting
US9850525B2 (en) 2014-01-29 2017-12-26 Agilent Technologies, Inc. CAS9-based isothermal method of detection of specific DNA sequence
EP4467654A3 (en) 2014-02-04 2025-02-19 Jumpcode Genomics, Inc. Genome fractioning
EP3126498A4 (en) 2014-03-20 2017-08-23 Université Laval Crispr-based methods and products for increasing frataxin levels and uses thereof
WO2015148680A1 (en) 2014-03-25 2015-10-01 Ginkgo Bioworks, Inc. Methods and genetic systems for cell engineering
WO2015153791A1 (en) 2014-04-01 2015-10-08 Editas Medicine, Inc. Crispr/cas-related methods and compositions for treating herpes simplex virus type 2 (hsv-2)
US10507232B2 (en) 2014-04-02 2019-12-17 University Of Florida Research Foundation, Incorporated Materials and methods for the treatment of latent viral infection
WO2015153940A1 (en) 2014-04-03 2015-10-08 Massachusetts Institute Of Technology Methods and compositions for the production of guide rna
CN106460003A (zh) 2014-04-08 2017-02-22 北卡罗来纳州立大学 用于使用crispr相关基因rna引导阻遏转录的方法和组合物
ES2962509T3 (es) 2014-04-14 2024-03-19 Maxcyte Inc Métodos y composiciones para modificar ADN genómico
WO2015159068A1 (en) 2014-04-14 2015-10-22 Nemesis Bioscience Ltd Therapeutic
GB201406968D0 (en) 2014-04-17 2014-06-04 Green Biologics Ltd Deletion mutants
GB201406970D0 (en) 2014-04-17 2014-06-04 Green Biologics Ltd Targeted mutations
WO2015189693A1 (en) 2014-06-12 2015-12-17 King Abdullah University Of Science And Technology Targeted viral-mediated plant genome editing using crispr/cas9
WO2015200555A2 (en) 2014-06-25 2015-12-30 Caribou Biosciences, Inc. Rna modification to engineer cas9 activity
WO2016033298A1 (en) 2014-08-28 2016-03-03 North Carolina State University Novel cas9 proteins and guiding features for dna targeting and genome editing
WO2016084088A1 (en) 2014-11-26 2016-06-02 Ramot At Tel-Aviv University Ltd. Targeted elimination of bacterial genes
US12129471B2 (en) 2015-02-23 2024-10-29 Vertex Pharmaceuticals Incorporated Materials and methods for treatment of human genetic diseases including hemoglobinopathies
DE112016002056T5 (de) 2015-05-06 2018-02-08 Snipr Technologies Limited Verändern mikrobieller Populationen und Modifizieren von Mikrobiomen
EP3303607A4 (en) 2015-05-29 2018-10-10 North Carolina State University Methods for screening bacteria, archaea, algae, and yeast using crispr nucleic acids
US9580727B1 (en) 2015-08-07 2017-02-28 Caribou Biosciences, Inc. Compositions and methods of engineered CRISPR-Cas9 systems using split-nexus Cas9-associated polynucleotides
US20180258411A1 (en) 2015-09-25 2018-09-13 Tarveda Therapeutics, Inc. Compositions and methods for genome editing
WO2017058751A1 (en) 2015-09-28 2017-04-06 North Carolina State University Methods and compositions for sequence specific antimicrobials
EP4089175A1 (en) 2015-10-13 2022-11-16 Duke University Genome engineering with type i crispr systems in eukaryotic cells
WO2017112620A1 (en) 2015-12-22 2017-06-29 North Carolina State University Methods and compositions for delivery of crispr based antimicrobials
US11504404B2 (en) 2016-02-24 2022-11-22 Crown Laboratories, Inc. Skin probiotic formulation

Similar Documents

Publication Publication Date Title
JP2018518163A5 (enExample)
Grose et al. Understanding the enormous diversity of bacteriophages: the tailed phages that infect the bacterial family Enterobacteriaceae
FI3307872T3 (fi) Menetelmiä ja koostumuksia nukleiinihappojen ja rna-pohjaisten antimikrobien tehokkaaseen antamiseen
BR112019003327A2 (pt) nucleases manipuladas de alvo específico
JP2015133993A5 (enExample)
RU2018117360A (ru) Сконструированные нуклеиновые кислоты, нацеленные на нуклеиновую кислоту
WO2015126766A8 (en) Methods and compositions for dna profiling
JP2017516475A5 (enExample)
WO2015081229A3 (en) Selective amplification of nucleic acid sequences
RU2016123086A (ru) Способы и композиции для лечения болезни хантингтона
WO2015196128A3 (en) Alternative nucleic acid molecules and uses thereof
JP2016528887A5 (enExample)
JP2012223202A5 (enExample)
WO2016140726A3 (en) Triggered assembly of metafluorophores
JP2015128433A5 (enExample)
CN116134150A (zh) 病原体特异性核酸片段及其应用
CN110603327A (zh) Pcr引物对及其应用
Goren et al. Programming bacteriophages by swapping their specificity determinants
WO2020139152A8 (en) Gene therapy dna vector and its application
WO2020036654A3 (en) Highly knotted molecular topologies from single-stranded nucleic acids
PH12019502063A1 (en) Nucleic acid derivative having immunostimulatory activity
CO2021006938A2 (es) Agente de corte de adn
JP2016108250A5 (enExample)
Balachandran et al. Complete Genome Sequence of Staphylococcus aureus Strain Wood 46
PL409330A1 (pl) Szczepy Staphylococcus aureus do produkcji monoklonalnych preparatów fagowych pozbawionych zanieczyszczeń plazmidowym DNA